Strengthening the Quality, Accessibility, and Sustainability of the National Health Laboratory Services (NHLS) in United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR)

The summary for the Strengthening the Quality, Accessibility, and Sustainability of the National Health Laboratory Services (NHLS) in United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control CGH, which is the U.S. government agency offering this grant.

Strengthening the Quality, Accessibility, and Sustainability of the National Health Laboratory Services (NHLS) in United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR): Timely and reliable laboratory data are an essential component of a well-functioning national health system. This FOA will support strengthening the quality, accessibility, and sustainability of the NHLS across a six-tiered network, i.e., at the national, zonal, regional, district, health center, and dispensary levels. Technical assistance will focus on improving the quality assurance of HIV rapid testing, TB microscopy and GeneXpert; Early Infant Diagnosis (EID) and Viral Load (VL) testing; establishment and maintenance of efficient sample referral system and transport networks; implementation of laboratory Quality Management Systems; implementation of Laboratory Information Management Systems; scale up of EID and VL monitoring programs; quantification and forecasting of laboratory commodities; HIV Drug Resistance Surveillance; and, effective use of laboratory data for program management.